Updated Jul 16, 2026
Barry Richard has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $551K. Historical track record: 5/5 stars across 5 tracked purchases.
Richard Barry is the President and CEO of Cassava Sciences Inc, a biotechnology company focused on developing treatments and diagnostics for Alzheimer's disease. He has held multiple roles within the company, including Director, and has been involved in its strategic direction and operations.
| Role | Insider |
|---|---|
| Notability | 30/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 10000% |
| 90-day win rate | 10000% |
| Avg 5-day return | +4382.53% |
| Avg 30-day return | +8629.55% |
| Avg 90-day return | +2029.89% |
| Best 30-day return | +9342.11% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-06 | SRPT | Sarepta Therapeutics, Inc. | A — Grant or award | 16.9K | — | |
| 2025-09-22 | SAVA | CASSAVA SCIENCES INC | P — Open-market purchase | 7.2K | $2.28 | $16K |
| 2025-09-18 | SAVA | CASSAVA SCIENCES INC | P — Open-market purchase | 46.9K | $2.29 | $107K |
| 2025-09-18 | SAVA | CASSAVA SCIENCES INC | P — Open-market purchase | 400 | $2.25 | $900 |
| 2025-09-18 | SAVA | CASSAVA SCIENCES INC | P — Open-market purchase | 185.2K | $2.24 | $415K |
| 2025-09-18 | SAVA | CASSAVA SCIENCES INC | P — Open-market purchase | 5.4K | $2.13 | $12K |
Richard Barry is the President and CEO of Cassava Sciences Inc, a biotechnology company focused on developing treatments and diagnostics for Alzheimer's disease. He has held multiple roles within the company, including Director, and has been involved in its strategic direction and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 5 open-market purchases ($551K) and 0 open-market sales () across all tracked filings.
Across 5 tracked purchases, Barry Richard averaged +8629.6% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Barry Richard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.